Core Laboratories
CLB
374 hedge funds and large institutions have $6.15B invested in Core Laboratories in 2018 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 116 increasing their positions, 135 reducing their positions, and 31 closing their positions.
71% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 31
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
30% more call options, than puts
Call options by funds: $36.2M | Put options by funds: $27.9M
12% more capital invested
Capital invested by funds: $5.49B → $6.15B (+$667M)
5% more funds holding
Funds holding: 355 → 374 (+19)
1.72% less ownership
Funds ownership: 114.97% → 113.24% (-1.7%)
14% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 135
Top Buyers
| 1 |
APG Asset Management
Amsterdam,
Netherlands
|
+$51.5M |
| 2 |
Barclays
London,
United Kingdom
|
+$33.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$32.5M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$30.3M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$29.7M |
Top Sellers
| 1 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$103M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$94.3M |
| 3 |
ClearBridge Investments
New York
|
-$22.9M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$19.3M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$19.2M |
CLB Hedge Fund Activity: Q2 2018 in Review
374 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2018, worth a combined $6.15B — up 12% from $5.49B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new CLB positions and 31 closed out — a net gain of 22 holders — while 116 added to existing stakes and 135 trimmed.
The largest buyer was APG Asset Management, adding an estimated $51.5M. The largest seller was Sustainable Growth Advisers, exiting entirely with an estimated $103M sold.
- 374 institutional investors held Core Laboratories (CLB) as of Q2 2018, up from 355 in Q1 2018.
- Funds reported $6.15B of Core Laboratories stock for Q2 2018, up 12% quarter-over-quarter.
- 53 funds opened new Core Laboratories positions in Q2 2018 and 31 closed out, a net change of +22 holders.
- The largest Core Laboratories buyer in Q2 2018 was APG Asset Management, an estimated $51.5M added.
- The largest Core Laboratories seller in Q2 2018 was Sustainable Growth Advisers, an estimated $103M sold.
Based on aggregated 13F filings for Q2 2018.